208
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Bioavailability Enhancement of Poorly Water Soluble and Weakly Acidic New Chemical Entity with 2-Hydroxy Propyl-β-Cyclodextrin: Selection of Meglumine, a Polyhydroxy Base, as a Novel Ternary Component

, , , , , , & show all
Pages 443-451 | Received 03 Oct 2005, Accepted 07 Jan 2006, Published online: 07 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Alaa Y. Bazeed, Ebtessam A. Essa, Ahmed Nouh & Gamal M. El Maghraby. (2020) Co-processing of nateglinide with meglumine for enhanced dissolution rate: in vitro and in vivo evaluation. Drug Development and Industrial Pharmacy 46:10, pages 1676-1683.
Read now
Vijay Gyanani, Basavaraj Siddalingappa & Guru V. Betageri. (2015) Evaluation of various processes for simultaneous complexation and granulation to incorporate drug–cyclodextrin complexes into solid dosage forms. Drug Development and Industrial Pharmacy 41:11, pages 1856-1863.
Read now
Carolina Aloisio, Anselmo Gomes de Oliveira & Marcela Longhi. (2014) Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug. Drug Development and Industrial Pharmacy 40:7, pages 919-928.
Read now
Yi Shi, William Porter, Thomas Merdan & Luk Chiu Li. (2009) Recent advances in intravenous delivery of poorly water-soluble compounds. Expert Opinion on Drug Delivery 6:12, pages 1261-1282.
Read now

Articles from other publishers (10)

Xiaoshuang He, Yuanfeng Wei, Shiru Wang, Jianjun Zhang, Yuan Gao, Shuai Qian, Zunting Pang & Weili Heng. (2022) Improved Pharmaceutical Properties of Honokiol via Salification with Meglumine: an Exception to Oft-quoted ∆pKa Rule. Pharmaceutical Research 39:9, pages 2263-2276.
Crossref
Abbe Haser, Tu Cao, Joseph W. Lubach & Feng Zhang. (2018) In Situ Salt Formation during Melt Extrusion for Improved Chemical Stability and Dissolution Performance of a Meloxicam–Copovidone Amorphous Solid Dispersion . Molecular Pharmaceutics 15:3, pages 1226-1237.
Crossref
Abbe Haser, Siyuan Huang, Tony Listro, David White & Feng Zhang. (2017) An approach for chemical stability during melt extrusion of a drug substance with a high melting point. International Journal of Pharmaceutics 524:1-2, pages 55-64.
Crossref
Sumit S. Vakani, Apeksha Kajwe, Vasanti Suvarna & Atul P. Sherje. (2015) Influence of auxiliary agents on solubility and dissolution profile of repaglinide with hydroxypropyl-β-cyclodextrin: inclusion complex formation and its solid-state characterization. Journal of Inclusion Phenomena and Macrocyclic Chemistry 83:3-4, pages 239-250.
Crossref
Haiying Li, Lilan Ma, Xiaxia Li, Xin Cui, Wenzhi Yang, Shigang Shen & Mingmao Chen. (2015) A simple and effective method to improve bioavailability of glimepiride by utilizing hydrotropy technique. European Journal of Pharmaceutical Sciences 77, pages 154-160.
Crossref
S Basavaraj & Guru V. Betageri. (2014) Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges. Acta Pharmaceutica Sinica B 4:1, pages 3-17.
Crossref
Mohd Aftab Alam, Fahad I. Al-Jenoobi & Abdullah M. Al-mohizea. (2013) Commercially bioavailable proprietary technologies and their marketed products. Drug Discovery Today 18:19-20, pages 936-949.
Crossref
Dan Wang, Haiyan Li, Jingkai Gu, Tao Guo, Shuo Yang, Zhen Guo, Xueju Zhang, Weifeng Zhu & Jiwen Zhang. (2013) Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: Simultaneous enhancement of drug solubility and stability in aqueous solutions. Journal of Pharmaceutical and Biomedical Analysis 83, pages 141-148.
Crossref
Mayur Sangwai & Pradeep Vavia. (2013) Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: Improved solubility and reduced pharmacokinetic variability. International Journal of Pharmaceutics 453:2, pages 423-432.
Crossref
Wei-Qin (Tony) Tong & Hong Wen. 2008. Water-Insoluble Drug Formulation, Second Edition. Water-Insoluble Drug Formulation, Second Edition 133 159 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.